Therapeutic recommendations of the International Homeopathic Society of Supportive Care in Oncology (IHSSCO)

Bagot, Jean-Lionel; Karp, Jean-Claude; Messerschmitt, Christiane; Lavallée, Véronique; Blajman, Hervé; Veron, Fabrice; Fischer-Lévy, Isabelle; Tourneur-Bagot, Odile; Wagner, Jean-Philippe

doi:10.1016/j.revhom.2017.10.015

Cited by 9 publications

(14 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Compiled according to formal consensus methods, it oversees and facilitates this prescription for all doctors, whether they are GPs or oncologists, qualified in homeopathy or not. 13 The 98% satisfaction rate may be surprising. Yet it confirms the figures found in other studies.…”

Section: Discussionmentioning

confidence: 99%

Use of Homeopathy in Integrative Oncology in Strasbourg, France: Multi-center Cross-Sectional Descriptive Study of Patients Undergoing Cancer Treatment

Bagot

Legrand²,

Theunissen

2021

Homeopathy

View full text Add to dashboard Cite

Context The use of homeopathy in oncological supportive care seems to be progressing. The first French prevalence study, performed in 2005 in Strasbourg, showed that only 17% of the subjects were using it. What is the situation 12 years later? Materials and Methods This is a descriptive study, using a questionnaire identical to that used in 2005, on 633 patients undergoing treatment in three anti-cancer centers in Strasbourg. The results of the “homeopathy” sub-group were extracted and studied. Results Of the 535 patients included, 164 used homeopathy: that is 30.7%. The main purpose of its use was to reduce the side effects of cancer treatments (75%). Among the users, 82.6% were “somewhat” or “very” satisfied, against “quite” satisfied for 15.5%, and “not at all” satisfied for 1.9%. The homeopathic treatment was prescribed by a doctor in 75.6% of the cases; the general practitioner was kept informed in 87% of the cases and the oncologist in 82%. Fatigue, pain, nausea, anxiety, sadness and diarrhea were improved in 80% of the cases. However, alopecia, weight disorders and loss of libido were the least improved symptoms. The use of homeopathy was significantly associated with the female sex. Conclusion With a prevalence of 30.7%, homeopathy is the most used complementary medicine in integrative oncology in Strasbourg. Over 12 years, we have witnessed an increase of 83% in its use in the same city. Almost all respondents declare themselves satisfied and tell their doctors more readily than in 2005.

show abstract

Section: Discussionmentioning

confidence: 99%

Use of Homeopathy in Integrative Oncology in Strasbourg, France: Multi-center Cross-Sectional Descriptive Study of Patients Undergoing Cancer Treatment

Bagot

Legrand²,

Theunissen

2021

Homeopathy

View full text Add to dashboard Cite

show abstract

“…Homeopathy is an important component of integrative care in most European centers [9] and, given its frequent use by cancer patients in France, would seem to be one of the most important integrative therapies. Advocacy and educational support for homeopathy in integrated care is available from the International Homeopathic Society for Supportive Care in Oncology (IHSSCO), established in 2016, whose aim is to facilitate and develop the practice, teaching, research, and promotion of homeopathic therapy as part of SCO [24]. IHSSCO has identified 15 hospitals offering homeopathic consultation in SCO across France and has published therapeutic recommendations developed by expert consensus to guide use [25].…”

Section: Discussionmentioning

confidence: 99%

Perceptions of homeopathy in supportive cancer care among oncologists and general practitioners in France

Bagot¹,

Theunissen

Serral

2021

Support Care Cancer

View full text Add to dashboard Cite

Objectives In France, homeopathy is the most frequently used complementary therapy in supportive care in oncology (SCO); its use is steadily increasing. However, data is limited about the perception and relevance of homeopathy by oncologists and general practitioners (GPs) both with and without homeopathic training (HGPs and NHGPs, respectively). Our aim was to evaluate French physicians’ perceptions of homeopathy to clarify its place in SCO through two original observation survey-based studies. Materials and methods Two cross-sectional surveys of French physicians were conducted involving (1) 150 specialist oncologists; (2) 97 HGPs and 100 NHGPs. Questions evaluated physician attitudes to homeopathy and patterns of use of homeopathic therapies in patients requiring SCO. Survey responses were described and analyzed on the basis of physician status. Results Ten percent of oncologists stated they prescribe homeopathy; 36% recommend it; 54% think that homeopathy is potentially helpful in SCO. Two-thirds of the NHGPs sometimes prescribe homeopathy in the context of SCO and 58% regularly refer their patients to homeopathic doctors. HGPs have a positive perception of homeopathy in SCO. Conclusions Homeopathy is viewed favorably as an integrated SCO therapy by the majority of French physicians involved with cancer patients—oncologists and GPs. Symptoms of particular relevance include fatigue, anxiety, peripheral neuropathy, sleep disturbance, and hot flashes. In such clinical situations, response to conventional therapies may be suboptimal and homeopathy is considered a reliable therapeutic option. These two studies highlight the fact that homeopathy has gained legitimacy as the first complementary therapy in SCO in France.

show abstract

“…The International Homeopathic Society for Supportive Care in Oncology (IHSSCO; shisso-info.com ) was established in 2016, to facilitate and develop practice, teaching, research and promotion of homeopathic therapy in IO care. 22 Treatment recommendations developed by expert consensus have been published for use of homeopathy to alleviate symptoms before, during and following primary treatment (surgery, chemotherapy, radiotherapy, and targeted/hormonal therapy) and as palliative care; at each stage, patients can benefit from an individualized homeopathic consultation. 23 Homeopathic treatments are often given for symptoms less responsive to conventional care (e.g., fatigue, hot flashes, musculoskeletal pain, emotional disorders) and these IHSSCO recommendations are based on the best available evidence.…”

Section: Country Perspectivesmentioning

confidence: 99%

“… 22 Treatment recommendations developed by expert consensus have been published for use of homeopathy to alleviate symptoms before, during and following primary treatment (surgery, chemotherapy, radiotherapy, and targeted/hormonal therapy) and as palliative care; at each stage, patients can benefit from an individualized homeopathic consultation. 23 Homeopathic treatments are often given for symptoms less responsive to conventional care (e.g., fatigue, hot flashes, musculoskeletal pain, emotional disorders) and these IHSSCO recommendations are based on the best available evidence. 24 - 30 Much is derived from observational studies and personal experience; however, supportive data from a pragmatic RCT exists for the benefits of homeopathy in management of adverse effects of chemotherapy, immunotherapy, and hormonal therapy.…”

Section: Country Perspectivesmentioning

confidence: 99%

Integrative Oncology: An International Perspective from Six Countries

Tolédano

Rao²,

Frenkel

et al. 2021

Integr Cancer Ther

Self Cite

View full text Add to dashboard Cite

In June 2019, a meeting was held in Paris in which experts from different countries (Israel, Spain, Belgium, Italy, USA, and France) met to discuss a selection of topics in integrative oncology (IO). The objectives were to draw on the delegates’ experience and expertise to begin an international collaboration, sharing details of differing existing models and discussing future perspectives to help define and guide practice in IO and define unmet needs. This report presents a summary of the meeting’s main presentations, and also reports on the experts’ responses to a questionnaire examining different aspects of IO service delivery, infrastructure, and utilization.

show abstract

Therapeutic recommendations of the International Homeopathic Society of Supportive Care in Oncology (IHSSCO)

Cited by 9 publications

References 20 publications

Use of Homeopathy in Integrative Oncology in Strasbourg, France: Multi-center Cross-Sectional Descriptive Study of Patients Undergoing Cancer Treatment

Use of Homeopathy in Integrative Oncology in Strasbourg, France: Multi-center Cross-Sectional Descriptive Study of Patients Undergoing Cancer Treatment

Perceptions of homeopathy in supportive cancer care among oncologists and general practitioners in France

Integrative Oncology: An International Perspective from Six Countries

Contact Info

Product

Resources

About